HRTX Heron Therapeutics

Watchlist

1.780
+0.130+7.88%

Close Feb 14 16:00 ET

1.770
-0.010-0.57%

Post 19:01 ET

270.73MMarket Cap-11.13P/E (TTM)

About Heron Therapeutics Company

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Company Profile

SymbolHRTX

Company NameHeron Therapeutics

Listing DateJan 23, 2014

Issue Price7.00

Founded1983

CEOMr. Craig A. Collard

MarketNASDAQ

Employees126

Fiscal Year Ends12-31

Address100 Regency Forest Drive,Suite 300

CityCary

ProvinceNorth Carolina

CountryUnited States of America

Zip Code27518

Phone1-858-251-4400

Websitehttp://www.herontx.com

Company Executives

Name
Position
Salary

Craig A. Collard
Director and Chief Executive Officer
10.78M

Ira Duarte
Chief Accounting Officer, Executive Vice President and Chief Financial Officer
1.53M

Dr. William P. Forbes
Executive Vice President and Chief Development Officer
1.46M

Adam Morgan
Chairman of the Board
545.53K

Michael Kaseta
Director
--

Christian Waage
Independent Director
70.51K

Susan Rodriguez
Independent Director
65.63K

Dr. Sharmila Dissanaike, F.A.C.S.,M.D.
Independent Director
55.00K

Craig A. Johnson
Independent Director
79.03K

HRTX Heron Therapeutics

About Heron Therapeutics Company

Company Profile

Company Executives

Trending Stocks